Back to Trades
Sell4
JOHNSON & JOHNSON
JNJ
Total Value
$55.7M
Net $21.8M sold
Sales
$21.8M
4 transactions
Company Information
- Company Name
- JOHNSON & JOHNSON
- Ticker Symbol
- JNJ
- CIK
- 0000200406
Insider Information
- Name
- Wolk Joseph J
- Role
- Exec VP, CFO
- Location
- NEW BRUNSWICK, NJ
Officer
Filing Details
- Filing Date
- Feb 18, 2026
- Transaction Date
- Feb 13, 2026
- Accession Number
- 0000200406-26-000041
- Form Type
- 4
- Net Trading Amount
- -$21.8M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 13, 2026 | Common Stock | 37,463 | — | Exercise | — |
| Feb 13, 2026 | Common Stock | 15,948 | $244.55 | Tax Withholding | $3.9M |
| Feb 13, 2026 | Common Stock | 1,779 | — | Exercise | — |
| Feb 13, 2026 | Common Stock | 507 | $244.55 | Tax Withholding | $124.0K |
| Feb 15, 2026 | Common Stock | 1,971 | — | Exercise | — |
| Feb 15, 2026 | Common Stock | 858 | $243.45 | Tax Withholding | $208.9K |
| Feb 15, 2026 | Common Stock | 1,878 | — | Exercise | — |
| Feb 15, 2026 | Common Stock | 817 | $243.45 | Tax Withholding | $198.9K |
| Feb 17, 2026 | Common Stock | 19,241 | $115.67 | Exercise | $2.2M |
| Feb 17, 2026 | Common Stock | 19,241 | $242.99 | Sale | $4.7M |
| Feb 17, 2026 | Common Stock | 12,066 | $129.51 | Exercise | $1.6M |
| Feb 17, 2026 | Common Stock | 12,066 | $242.87 | Sale | $2.9M |
| Feb 17, 2026 | Common Stock | 33,386 | $131.94 | Exercise | $4.4M |
| Feb 17, 2026 | Common Stock | 33,386 | $242.75 | Sale | $8.1M |
| Feb 17, 2026 | Common Stock | 24,961 | $242.68 | Sale | $6.1M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 13, 2026 | Derivative | 37,463 | — | Exercise | — |
| Feb 13, 2026 | Derivative | 1,779 | — | Exercise | — |
| Feb 15, 2026 | Derivative | 1,971 | — | Exercise | — |
| Feb 15, 2026 | Derivative | 1,878 | — | Exercise | — |
| Feb 15, 2026 | Derivative | 53,793 | $243.45 | Grant/Award | $13.1M |
| Feb 15, 2026 | Derivative | 3,863 | — | Grant/Award | — |
| Feb 17, 2026 | Derivative | 19,241 | $115.67 | Exercise | $2.2M |
| Feb 17, 2026 | Derivative | 12,066 | $129.51 | Exercise | $1.6M |
| Feb 17, 2026 | Derivative | 33,386 | $131.94 | Exercise | $4.4M |
Footnotes
- (F1)Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.
- (F2)Shares withheld for payment of taxes upon vesting of PSUs.
- (F3)Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
- (F4)Shares withheld for payment of taxes upon vesting of RSUs.
- (F5)Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
- (F6)Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
- (F7)This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F8)This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F9)This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F10)This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F11)Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.
- (F12)Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
- (F13)Each RSU represents a contingent right to receive one share of Company Common Stock.
- (F14)Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
- (F15)Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
- (F16)Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.